Original Article| Volume 30, ISSUE 5, P1196-1204, October 2016

Efficacy and Safety of Fibrinogen Concentrate in Surgical Patients: A Meta-Analysis of Randomized Controlled Trials

Published:August 01, 2016DOI:


      To investigate the efficacy and safety of fibrinogen concentrate (FC) in surgical patients.


      Meta-analysis of randomized controlled studies (RCTs).




      Adult and pediatric surgical patients.


      A search of PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials, Transfusion Evidence Library, Google Scholar, and the proceedings from major international anesthesiology meetings up to February 1, 2016 for RCTs that compared FC with placebo or other comparators.

      Measurements and Main Results

      The primary outcome was all-cause mortality. Pooled risk ratios and mean differences (MDs) were computed with either fixed-effects or random-effects models. The study included 14 RCTs comprising 1,035 patients; the majority of patients underwent cardiac surgery. All-cause mortality was lower in the fibrinogen group (4/432 [0.9%] v 15/430 [3.5%]; risk ratio 0.26; 95% confidence interval [CI] 0.09-0.78; p = 0.02; heterogeneity statistic (l2) = 0%). The use of FC was associated with reduced bleeding (MD –127 mL; 95% CI –207 to –47; p = 0.002; I2= 54%) and a lower number of red blood cells units transfused versus comparator (MD –0.9; 95% CI –1.3 to –0.5; p<0.001; I2 = 42%). There were no differences in the rates of thrombotic events and myocardial infarction.


      In surgical patients, FC was associated with reduced bleeding and a lower number of red blood cell units transfused, and it also might reduce mortality. However, none of the analyzed trials was powered for estimation of survival and adverse events with FC use. Half of the included studies were of high or moderate risk of bias. The evidence primarily came from cardiac surgery settings.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Corral M.
        • Ferko N.
        • Hollmann S.
        • et al.
        Health and economic outcomes associated with uncontrolled surgical bleeding: A retrospective analysis of the Premier Perspectives Database.
        Clinicoecon Outcomes Res. 2015; 7: 409-421
        • Bolliger D.
        • Gorlinger K.
        • Tanaka K.A.
        Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution.
        Anesthesiology. 2010; 113: 1205-1219
        • Goodnough L.T.
        • Levy J.H.
        • Murphy M.F.
        Concepts of blood transfusion in adults.
        Lancet. 2013; 381: 1845-1854
        • Marik P.E.
        • Corwin H.L.
        Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature.
        Crit Care Med. 2008; 36: 2667-2674
        • Kozek-Langenecker S.
        • Sørensen B.
        • Hess J.R.
        • et al.
        Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: A systematic review.
        Crit Care. 2011; 15: R239
        • Mosesson M.W.
        Fibrinogen and fibrin structure and functions.
        J Thromb Haemost. 2005; 3: 1894-1904
        • Wikkelsø A.
        • Lunde J.
        • Johansen M.
        • et al.
        Fibrinogen concentrate in bleeding patients.
        Cochrane Database Syst Rev. 2013; 8: CD008864
        • Lunde J.
        • Stensballe J.
        • Wikkelsø A.
        • et al.
        Fibrinogen concentrate for bleeding-a systematic review.
        Acta Anaesthesiol Scand. 2014; 58: 1061-1074
        • [No authors listed]: Practice guidelines for perioperative blood management
        An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management.
        Anesthesiology. 2015; 122: 241-275
        • Kozek-Langenecker S.A.
        • Afshari A.
        • Albaladejo P.
        • et al.
        Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology.
        Eur J Anaesthesiol. 2013; 30: 270-382
      1. Higgins JPT, Green S, eds: Cochrane handbook for systematic reviews of interventions, version 5.1.0. Available at: 〈〉. Accessed April 27, 2016

        • Cui Y.
        • Hei F.
        • Long C.
        • et al.
        Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery.
        Artif Organs. 2010; 34: 955-960
        • Fenger-Eriksen C.
        • Jensen T.M.
        • Kristensen B.S.
        • et al.
        Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial.
        J Thromb Haemost. 2009; 7: 795-802
        • Galas F.R.
        • de Almeida J.P.
        • Fukushima J.T.
        • et al.
        Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: A randomized pilot trial.
        J Thorac Cardiovasc Surg. 2014; 148: 1647-1655
        • Jeppsson A.
        • Waldén K.
        • Roman-Emanuel C.
        • et al.
        Preoperative supplementation with fibrinogen concentrate in cardiac surgery: A randomized controlled study.
        Br J Anaesth. 2016; 116: 208-214
        • Karlsson M.
        • Ternström L.
        • Hyllner M.
        • et al.
        Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study.
        Thromb Haemost. 2009; 102: 137-144
        • Lancé M.D.
        • Ninivaggi M.
        • Schols S.E.
        • et al.
        Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: A prospective randomized intervention trial.
        Vox Sang. 2012; 103: 25-34
        • Najafi A.
        • Shariat Moharari R.
        • Orandi A.A.
        • et al.
        Prophylactic administration of fibrinogen concentrate in perioperative period of total hip arthroplasty: A randomized clinical trial study.
        Acta Med Iran. 2014; 52: 804-810
        • Rahe-Meyer N.
        • Solomon C.
        • Hanke A.
        • et al.
        Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial.
        Anesthesiology. 2013; 118: 40-50
      2. Rahe-Meyer N: Oral presentation during 2015 year Annual Congress of the European Society of Anaesthesiology, Berlin, May 30-June 2, 2015

        • Ranucci M.
        • Baryshnikova E.
        • Crapelli G.B.
        • et al.
        Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.
        J Am Heart Assoc. 2015; 4: e002066
      3. Sabate A, Gutierrez R, Beltran J, et al: Impact of pre-emptive fibrinogen concentrate on transfusion requirements in liver transplantation: A multicenter, randomized, double-blind, placebo-controlled trial. Am J Transplant 2016 Feb 16. [Epub ahead of print]

        • Sadeghi M.
        • Atefyekta R.
        • Azimaraghi O.
        • et al.
        A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery.
        Braz J Anesthesiol. 2014; 64: 253-257
        • Tanaka K.A.
        • Egan K.
        • Szlam F.
        • et al.
        Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: Preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.
        Transfusion. 2014; 54: 109-118
        • Wikkelsø A.J.
        • Edwards H.M.
        • Afshari A.
        • et al.
        Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: Randomized controlled trial.
        Br J Anaesth. 2015; 114: 623-633
        • Ponschab M.
        • Landoni G.
        • Biondi-Zoccai G.
        • et al.
        Recombinant activated factor VII increases stroke in cardiac surgery: A meta-analysis.
        J Cardiothorac Vasc Anesth. 2011; 25: 804-810
        • Fergusson D.A.
        • Hébert P.C.
        • Mazer C.D.
        • et al.
        A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
        N Engl J Med. 2008; 358: 2319-2331
        • Guzzetta N.A.
        • Allen N.N.
        • Wilson E.C.
        • et al.
        Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass.
        Anesth Analg. 2015; 120: 405-410
        • Levy J.H.
        • Dutton R.P.
        • Hemphill 3rd, J.C.
        • et al.
        Multidisciplinary approach to the challenge of hemostasis.
        Anesth Analg. 2010; 110: 354-364
        • Parekh A.K.
        • Barton M.B.
        The challenge of multiple comorbidity for the US health care system.
        JAMA. 2010; 303: 1303-1304
        • Ranucci M.
        • Baryshnikova E.
        • Simeone F.
        • et al.
        Moderate-degree acidosis is an independent determinant of postoperative bleeding in cardiac surgery.
        Minerva Anestesiol. 2015; 81: 885-893
        • Ranucci M.
        Hemostatic and thrombotic issues in cardiac surgery.
        Semin Thromb Hemost. 2015; 41: 84-90
        • Hiippala S.T.
        • Myllyla G.J.
        • Vahtera E.M.
        Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates.
        Anesth Analg. 1995; 81: 360-365
        • Fenger-Eriksen C.
        • Lindberg-Larsen M.
        • Christensen A.Q.
        • et al.
        Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations.
        Br J Anaesth. 2008; 101: 769-773
        • Fenger-Eriksen C.
        • Ingerslev J.
        • Sørensen B.
        Fibrinogen concentrate—a potential universal hemostatic agent.
        Expert Opin Biol Ther. 2009; 9: 1325-1333
      4. CSL Behring. RiaSTAP prescribing information. Available at: 〈〉. Accessed 1 November 1, 2015

        • Solomon C.
        • Pichlmaier U.
        • Schoechl H.
        • et al.
        Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.
        Br J Anaesth. 2010; 104: 555-562
        • Costa-Filho R.
        • Hochleitner G.
        • Wendt M.
        • et al.
        Over 50 years of fibrinogen concentrate.
        Clin Appl Thromb Hemost. 2016; 22: 109-114
        • Manco-Johnson M.J.
        • Dimichele D.
        • Castaman G.
        • et al.
        Pharmacokinetics and safety of fibrinogen concentrate.
        J Thromb Haemost. 2009; 7: 2064-2069
        • Waldén K.
        • Jeppsson A.
        • Nasic S.
        • et al.
        Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations.
        Ann Thorac Surg. 2014; 97: 1199-1206
        • Kindo M.
        • Hoang Minh T.
        • Gerelli S.
        • et al.
        Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass.
        Thromb Res. 2014; 134: 360-368
        • Gielen C.
        • Dekkers O.
        • Stijnen T.
        • et al.
        The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: A systematic review and meta-analysis.
        Interact Cardiovasc Thorac Surg. 2014; 18: 292-298
        • Velik-Salchner C.
        • Haas T.
        • Innerhofer P.
        • et al.
        The effect of fibrinogen concentrate on thrombocytopenia.
        J Thromb Haemost. 2007; 5: 1019-1025
        • Lang T.
        • Johanning K.
        • Metzler H.
        • et al.
        The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia.
        Anesth Analg. 2009; 108: 751-758
        • Aubron C.
        • Reade M.C.
        • Fraser J.F.
        • et al.
        Efficacy and safety of fibrinogen concentrate in trauma patients—a systematic review.
        J Crit Care. 2014; 29 (471.e11-17)
        • Fassl J.
        • Lurati Buse G.
        • Filipovic M.
        • et al.
        Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery.
        Br J Anaesth. 2015; 114: 225-234
        • Solomon C.
        • Gröner A.
        • Ye J.
        • et al.
        Safety of fibrinogen concentrate: Analysis of more than 27 years of pharmacovigilance data.
        Thromb Haemost. 2015; 113: 759-771